Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 3.780K / 8.668M |
Day Range | - - - |
52 Wk Range | 3.532 - 11.360 |
Market Cap | $675.974M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 45.66% |
Days to Cover | 8.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Cogent Biosciences (NASDAQ:COGT), Korro Bio (NASDAQ:KRRO), Pharming (NASDAQ:PHAR), Cullinan Oncology (NASDAQ:CGEM) and Olema Pharmaceuticals (NASDAQ:OLMA).
The latest price target for Novavax (NASDAQ: NVAX) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 19.00 expecting NVAX to rise to within 12 months (a possible 293.37% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $4.83 last updated Today at March 28, 2024 at 5:22 AM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.